Regions

The following classification of the documents is based on the geographical region to which these documents refer/apply to. Publications are available in HTML, PDF , DOC or XLS format. Click on the corresponding icon to open the publication.
Expand the sub-collections menu.
3218 documents on 65 pages
 
 
Open this document and view its content

10 Años de CFI - Informe sobre los logros 1996 – 2006 [English] [French]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Supply Management

Year:

2007;

Pages:

6;

Publishers:

WHO Headquarters in Geneva

Related documents:

Directrices de seguridad para la eliminación de productos farmacéuticos no deseados durante y después de una emergencia
Principios prácticos para efectuar buenas adquisiciones de productos farmacéuticos
Guidelines for Medicine Donations - Revised 2010. (First Edition 1996, Second Edition 1999, Third Edition 2011)
El Botiquín Médico Interinstitucional de Emergencia de 2011: Medicamentos y dispositivos médicos para atender a 10 000 personas durante tres meses aproximadamente
Model Quality Assurance System for Procurement Agencies. WHO Technical Report Series, No. 986, 2014, Annex 3
Interagency List of Essential Medical Devices for Reproductive Health, 2008
Interagency list of priority medical devices for essential interventions for reproductive, maternal, newborn and child health. 2015
The Interagency List of Essential Medicines for Reproductive Health 2006

Related links:

http://www.who.int/medicines/areas/policy/ipc/en/

Regions:

Global
 
Open this document and view its content

10 Stories that Mattered in Access to Medicines in 2011 - Médecins Sans Frontières (MSF Access Campaign)

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Financing
Medicine Access and Rational Use > Pricing

Year:

2011;

Pages:

13;

Publishers:

Médecins sans Frontières (MSF)

Regions:

Global
 
Open this document and view its content

10ème Anniversaire de l’IPC - Bilan des réalisations de l’IPC de 1996 à 2006 [English] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Supply Management

Year:

2007;

Pages:

6;

Publishers:

WHO Headquarters in Geneva

Related documents:

Liste inter-institutions des médicaments essentiels pour la santé génésique 2006
Principes directeurs pour l'élimination sans risques des produits pharmaceutiques non utilisés pendant et après les situations d'urgence
Principes opérationnels de bonnes pratiques pour les achats de produits pharmaceutiques
Guidelines for Price Discounts of Single-Source Pharmaceuticals
Guidelines for Medicine Donations - Revised 2010. (First Edition 1996, Second Edition 1999, Third Edition 2011)
Kit sanitaire d’urgence interinstitutions 2011 : Médicaments et dispositifs médicaux pour une population de 10 000 personnes pendant environ 3 mois
Système modèle d’assurance de la qualité pour agences d’approvisionnement. OMS, Série de Rapports techniques, No. 986, 2014, Annexe 3

Related links:

http://www.who.int/medicines/areas/policy/ipc/en/

Regions:

Global
 
Open this document and view its content

11th International Conference of Drug Regulatory Authorities - Proceedings

Year:

2006;

Pages:

73;

Publishers:

Spanish Agency for Medicines and Health Products
WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

11th International Conference of Drug Regulatory Authorities - Progress Report and Recommendations

Year:

2006;

Pages:

24;

Publishers:

Spanish Agency for Medicines and Health Products
WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

12th International Conference of Drug Regulatory Authorities - Proceedings

Year:

2006;

Pages:

89;

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

12th International Conference of Drug Regulatory Authorities - Recommendations

Year:

2006;

Pages:

15;

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

13th International Conference of Drug Regulatory Authorities (ICDRA) Berne, Switzerland, 16-19 September 2008. ICDRA: Medicines Agencies Decide Future Action

Subjects:

Quality and Safety: Medicines > Quality Assurance
Quality and Safety: Medicines > Regulatory Support

Year:

2008;

Pages:

19;

Publishers:

WHO Headquarters in Geneva

Related links:

http://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/en/index.html

Regions:

Global
 
Open this document and view its content

15th International Conference of Drug Regulatory Authorities (ICDRA), Tallinn, Estonia, 23–26 October 2012

Subjects:

Quality and Safety: Medicines > Regulatory Support

Year:

2012;

Pages:

23;

Publishers:

WHO Headquarters in Geneva

Related links:

http://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/en/index.html

Regions:

Global
 
Open this document and view its content

16th International Conference of Drug Regulatory Authorities (ICDRA) and its recommendations. As featured in WHO Drug Information Vol. 28, No.3, 2014. (WHO Pharmaceuticals Newsletter 2014, No. 6)

Subjects:

Medicine Information and Evidence for Policy > Information and Publications
Quality and Safety: Medicines > Safety and Efficacy

Year:

2014;

Pages:

10;

Publishers:

WHO Headquarters in Geneva

Related documents:

15th International Conference of Drug Regulatory Authorities (ICDRA), Tallinn, Estonia, 23–26 October 2012
16th International Conference of Drug Regulatory Authorities (ICDRA). (WHO Drug Information Vol. 28, No. 3, 2014)

Related links:

http://www.who.int/medicines/icdrahttp://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/en/http://www.who.int/medicines/areas/quality_safety/safety_efficacy/en/http://www.who.int/medicines/publications/newsletter/en/index.html

Regions:

Global
 
Open this document and view its content

16th International Conference of Drug Regulatory Authorities (ICDRA). (WHO Drug Information Vol. 28, No. 3, 2014)

Subjects:

Quality and Safety: Medicines > Regulatory Support

Year:

2014;

Pages:

10;

Publishers:

WHO Headquarters in Geneva

Related documents:

Guidelines on Evaluation of Similar Biotherapeutic Products (SBPs). WHO Expert Committee on Biological Standardization, Sixtieth report (19-23 October 2009). WHO Technical Report Series No. 977, 2013 - Annex 2
15th International Conference of Drug Regulatory Authorities (ICDRA), Tallinn, Estonia, 23–26 October 2012
WHO Drug Information Vol. 28, No. 3, 2014 - Recommended International Nonproprietary Names, List 72
17th International Conference of Drug Regulatory Authorities - ICDRA. (WHO Drug Information Vol. 30, No. 4, 2016)

Related links:

http://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/en/http://www.who.int/medicines/publications/druginformation/en/

Regions:

Global
 
Open this document and view its content

17th International Conference of Drug Regulatory Authorities - ICDRA. (WHO Drug Information Vol. 30, No. 4, 2016)

Subjects:

Quality and Safety: Medicines > Regulatory Support

Year:

2017;

Pages:

11;

Publishers:

WHO Headquarters in Geneva

Related documents:

16th International Conference of Drug Regulatory Authorities (ICDRA). (WHO Drug Information Vol. 28, No. 3, 2014)
Good Review Practices: Guidelines for National and Regional Regulatory Authorities. (WHO Drug Information Vol. 29, No. 1, 2015)
Good Review Practices: Guidelines for National And Regional Regulatory Authorities. WHO Technical Report Series, No. 992, 2015, Annex 9
WHO Drug Information Vol. 30, No. 4, 2016 - Proposed International Nonproprietary Names, List 116

Related links:

http://www.who.int/medicines/publications/druginformation/en/index.htmlhttp://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/en/http://www.icdra.co.za/

Regions:

Global
 
Open this document and view its content

2008年世界卫生报告 初级卫生保健—过去重要，现在更重要 / The World Health Report 2008. Primary Health Care Now More Than Ever [Arabic] [English] [French] [Russian] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Financing
Medicine Access and Rational Use > Primary Health Care

Year:

2008;

Pages:

142;

Publishers:

WHO Headquarters in Geneva

Related documents:

The World Medicines Situation 2011 (Chapters Currently Available)
The World Health Report 2010. Health Systems Financing: The Path to Universal Coverage (Chinese translation) 2010年世界卫生报告. 卫生系统筹资：实现全民覆盖的道路
2013年世界卫生报告. 全民健康覆盖研究 / The World Health Report 2013. Research for Universal Health Coverage

Related links:

http://www.who.int/whr/zh/http://www.who.int/medicines/en/

Regions:

Global
 
Open this document and view its content

2009 FIP Global Pharmacy Workforce Report

Subjects:

Medicine Programme Coordination > Human Resources for Pharmaceutical Sector

Year:

2009;

Pages:

92;

Publishers:

International Pharmaceutical Federation (FIP)

Related documents:

2012 FIP Global Pharmacy Workforce Report

Related links:

https://www.fip.org

Regions:

Global
 
Open this document and view its content

2012 FIP Global Pharmacy Workforce Report

Subjects:

Medicine Programme Coordination > Human Resources for Pharmaceutical Sector

Year:

2013;

Pages:

85;

Publishers:

International Pharmaceutical Federation (FIP)

Related links:

https://www.fip.org/humanresources

Regions:

Global
 
Open this document and view its content

2013 FIPEd Global Education Report

Subjects:

Medicine Programme Coordination > Human Resources for Pharmaceutical Sector

Year:

2013;

Pages:

54;

Publishers:

International Pharmaceutical Federation (FIP)

Related links:

http://www.fip.org/www/index.php?page=educationreports

Regions:

Global
 
Open this document and view its content

2013年世界卫生报告. 全民健康覆盖研究 / The World Health Report 2013. Research for Universal Health Coverage [Arabic] [English] [French] [Russian] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy

Year:

2013;

Pages:

166;

Publishers:

WHO Headquarters in Geneva

Related documents:

The New Global Health Agenda. Universal Health Coverage
Making Fair Choices on the Path to Universal Health Coverage. Final Report of the WHO Consultative Group on Equity and Universal Health Coverage
Making Fair Choices on the Path to Universal Health Coverage
WHA67.23 - Health Intervention and Technology Assessment in Support of Universal Health Coverage. WHA Resolution; Sixty-seventh World Health Assembly, 2014 (Chinese version) WHA67.23 - 为支持全民健康覆盖开展卫生干预和技术评估; 世界卫生大会, 67
Universal Health Coverage for Inclusive and Sustainable Development. A Synthesis of 11 Country Case Studies
Second WHO Global Forum on Medical Devices: Priority Medical Devices for Universal Health Coverage. 22–24 November 2013, Geneva, Switzerland
The World Health Report 2010. Health Systems Financing: The Path to Universal Coverage (Chinese translation) 2010年世界卫生报告. 卫生系统筹资：实现全民覆盖的道路
2008年世界卫生报告 初级卫生保健—过去重要，现在更重要 / The World Health Report 2008. Primary Health Care Now More Than Ever

Related links:

http://www.who.int/whr/zh/http://www.who.int/universal_health_coverage/zh/http://www.who.int/medicines/en/

Regions:

Global
 
Open this document and view its content

2015 Global Survey on Health Technology Assessment by National Authorities. Main Findings

Subjects:

Medicine Access and Rational Use > Financing
Medicine Access and Rational Use > Pricing
Health Technology Assessment > Evidence-based Medicine
Health Technology Assessment > Policies
Health Technology Assessment > Assessment Results
Health Technology Assessment > Cost Effectiveness
Health Technology Assessment > Clinical Effectiveness

Year:

2015;

Pages:

40;

Publishers:

WHO Headquarters in Geneva

Related documents:

Measuring Medicine Prices, Availability, Affordability and Price Components - 2nd Edition
WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations - Guide for Coordinators and Data Collectors
Options for Financing and Optimizing Medicines in Resource-poor Countries. Discussion Paper Number 7 - 2010
The Judgement Process in Evidence-based Medicine and Health Technology Assessment
Promoting Access to Medical Technologies and Innovation. Intersections Between Public Health, Intellectual Property and Trade
The World Health Report 2010. Health Systems Financing: The Path to Universal Coverage
Health Technology Assessment Methodologies for Developing Countries
Clinical Evidence for Medical Devices: Regulatory Processes Focusing on Europe and the United States of America: Background Paper 03, August 2010
Sound Choices: Enhancing Capacity for Evidence-Informed Health Policy
Making Fair Choices on the Path to Universal Health Coverage. Final Report of the WHO Consultative Group on Equity and Universal Health Coverage
WHA67.23 - Health Intervention and Technology Assessment in Support of Universal Health Coverage. WHA Resolution; Sixty-seventh World Health Assembly, 2014
Health Technology Assessment of Medical Devices. (WHO Medical Device Technical Series)
Medicines in Health Systems: Advancing Access, Affordability and Appropriate Use
Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research
Developing an Approach for Using Health Technology Assessments in Reimbursement Systems for Medical Products. Geneva, Switzerland, July 20-21, 2015
Health Technology Assessment and Health Policy-making in Europe. Current Status, Challenges and Potential. Observatory Studies Series No 14

Related links:

http://www.who.int/health-technology-assessment/en/http://www.who.int/medical_devices/en/http://www.who.int/medicines/areas/access/en/

Regions:

Global
 
Open this document and view its content

The 2016 Access to Medicine Index. Methodology 2015

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Information and Evidence for Policy > Monitoring and Evaluation

Year:

2015;

Pages:

64;

Publishers:

Access to Medicine Foundation

Related documents:

Big Pharma and Social Responsibility — The Access to Medicine Index
Access to Medicine Index - Methodology Report 2013 for the 2014 Access to Medicine Index
The Access to Medicine Index 2014
Rapid Access to Investigational Vaccines: an Analysis of Access Provisions. Vaccine Pipeline Analysis, 30 September 2015
Access to Medicine Index 2016. November 2016

Related links:

http://www.accesstomedicineindex.org/http://www.who.int/medicines/areas/policy/en/

Regions:

Global
 
Open this document and view its content

25 Questions and Answers on Health and Human Rights [Arabic] [Chinese] [French] [Russian] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Human Rights

Year:

2002;

Pages:

36;

Publishers:

WHO Headquarters in Geneva

Related documents:

IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014
Essential Medicines and Human Rights: What Can They Learn From Each Other?
Is Access to Essential Medicines As Part Of The Fulfilment of the Right to Health Enforceable Through the Courts?
Health, Essential Medicines, Human Rights & National Constitutions
The World Medicines Situation 2011 - Access to Essential Medicines as Part of the Right to Health
A Right to Health
Respecting the Right to Access to Medicines: Implications of the UN Guiding Principles on Business and Human Rights for the Pharmaceutical Industry
Health Technologies and Pharmaceuticals Division of Health Systems and Public Health. Annual Report 2012, WHO/Europe. Access to essential, quality medicines and health technologies is a fundamental part of every person’s right to health
The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property. (The South Centre - Research Papers 35, January 2011)
The Doha Declaration Ten Years on and Its Impact on Access to Medicines and the Right to Health, 2011. Discussion Paper, UNDP

Related links:

http://www.who.int/hhr/en/http://www.who.int/medicines/areas/human_rights/en/

Regions:

Global
 
Open this document and view its content

25 Questions and Answers on Health and Human Rights (Arabic translation) [Chinese] [English] [French] [Russian] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Human Rights

Year:

2002;

Pages:

33;

Publishers:

WHO Headquarters in Geneva

Related documents:

IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014
Essential Medicines and Human Rights: What Can They Learn From Each Other?
Is Access to Essential Medicines As Part Of The Fulfilment of the Right to Health Enforceable Through the Courts?
Health, Essential Medicines, Human Rights & National Constitutions
The World Medicines Situation 2011 - Access to Essential Medicines as Part of the Right to Health
A Right to Health
Respecting the Right to Access to Medicines: Implications of the UN Guiding Principles on Business and Human Rights for the Pharmaceutical Industry
Health Technologies and Pharmaceuticals Division of Health Systems and Public Health. Annual Report 2012, WHO/Europe. Access to essential, quality medicines and health technologies is a fundamental part of every person’s right to health
The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property. (The South Centre - Research Papers 35, January 2011)
The Doha Declaration Ten Years on and Its Impact on Access to Medicines and the Right to Health, 2011. Discussion Paper, UNDP

Related links:

http://www.who.int/hhr/en/http://www.who.int/medicines/areas/human_rights/en/

Regions:

Global
 
Open this document and view its content

25 Questions and Answers on Health and Human Rights (Chinese translation) [Arabic] [English] [French] [Russian] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Human Rights

Year:

2002;

Pages:

17;

Publishers:

WHO Headquarters in Geneva

Related documents:

IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014
Essential Medicines and Human Rights: What Can They Learn From Each Other?
Is Access to Essential Medicines As Part Of The Fulfilment of the Right to Health Enforceable Through the Courts?
Health, Essential Medicines, Human Rights & National Constitutions
The World Medicines Situation 2011 - Access to Essential Medicines as Part of the Right to Health
A Right to Health
Respecting the Right to Access to Medicines: Implications of the UN Guiding Principles on Business and Human Rights for the Pharmaceutical Industry
Health Technologies and Pharmaceuticals Division of Health Systems and Public Health. Annual Report 2012, WHO/Europe. Access to essential, quality medicines and health technologies is a fundamental part of every person’s right to health
The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property. (The South Centre - Research Papers 35, January 2011)
The Doha Declaration Ten Years on and Its Impact on Access to Medicines and the Right to Health, 2011. Discussion Paper, UNDP

Related links:

http://www.who.int/hhr/en/http://www.who.int/medicines/areas/human_rights/en/

Regions:

Global
 
Open this document and view its content

25 Questions-Réponses sur la Santé et les Droits Humains [Arabic] [Chinese] [English] [Russian] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Human Rights

Year:

2002;

Pages:

34;

Publishers:

WHO Headquarters in Geneva

Related documents:

IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014
Essential Medicines and Human Rights: What Can They Learn From Each Other?
Is Access to Essential Medicines As Part Of The Fulfilment of the Right to Health Enforceable Through the Courts?
Health, Essential Medicines, Human Rights & National Constitutions
The World Medicines Situation 2011 - Access to Essential Medicines as Part of the Right to Health
A Right to Health
Respecting the Right to Access to Medicines: Implications of the UN Guiding Principles on Business and Human Rights for the Pharmaceutical Industry
Health Technologies and Pharmaceuticals Division of Health Systems and Public Health. Annual Report 2012, WHO/Europe. Access to essential, quality medicines and health technologies is a fundamental part of every person’s right to health
The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property. (The South Centre - Research Papers 35, January 2011)
The Doha Declaration Ten Years on and Its Impact on Access to Medicines and the Right to Health, 2011. Discussion Paper, UNDP

Related links:

http://www.who.int/hhr/en/http://www.who.int/medicines/areas/human_rights/en/

Regions:

Global
 
Open this document and view its content

25 Years of the WHO Essential Medicines Lists: Progress and Challenges

Subjects:

Medicine Information and Evidence for Policy > Information and Publications
Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Selection

Author:

Ford, Nathan; Gray, Andy; Laing, Richard; 't Hoen, Ellen; Waning, Brenda

Year:

2003;

Pages:

7;

Regions:

Global
 
Open this document and view its content

25 вопросов и ответов о здоровье и правах человека. (Russian translation) 25 Questions and Answers on Health and Human Rights [Arabic] [Chinese] [English] [French] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Human Rights

Year:

2002;

Pages:

36;

Publishers:

WHO Headquarters in Geneva

Related documents:

IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014
Essential Medicines and Human Rights: What Can They Learn From Each Other?
Is Access to Essential Medicines As Part Of The Fulfilment of the Right to Health Enforceable Through the Courts?
Health, Essential Medicines, Human Rights & National Constitutions
The World Medicines Situation 2011 - Access to Essential Medicines as Part of the Right to Health
A Right to Health
Respecting the Right to Access to Medicines: Implications of the UN Guiding Principles on Business and Human Rights for the Pharmaceutical Industry
Health Technologies and Pharmaceuticals Division of Health Systems and Public Health. Annual Report 2012, WHO/Europe. Access to essential, quality medicines and health technologies is a fundamental part of every person’s right to health
The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property. (The South Centre - Research Papers 35, January 2011)
The Doha Declaration Ten Years on and Its Impact on Access to Medicines and the Right to Health, 2011. Discussion Paper, UNDP

Related links:

http://www.who.int/hhr/en/http://www.who.int/medicines/areas/human_rights/en/

Regions:

Global
 
Open this document and view its content

3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Abstract Poster Book

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Financing
Medicine Access and Rational Use > Pricing

Year:

2015;

Pages:

32;

Publishers:

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies

Related documents:

Pharmaceuticals: Cost cointainment, Pricing, Reimbursement. World Bank, HNP Brief #7
Pharmaceutical Pricing and Reimbursement Information (PPRI), Austria, September 2008
Pharmaceutical Policies in European Countries in Response to the Global Financial Crisis - Southern Med Review Vol 4 Issue 2 Dec 2011
Pharmaceutical Pricing Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 9)
Pharmaceutical Pricing Policies in a Global Market. OECD Health Policy Studies
Cost-containment Policies in Public Pharmaceutical Spending in the EU. Economic Papers 461. September 2012 (European Economy/European Commission)
The World Medicines Situation 2011 (Chapters Currently Available)
Pharma Futures. Pathways to Value: Pharma in a Changing World. PharmaFutures Global Conclusions
Priority Medicines for Europe and the World 2013 Update (EMP Research Series No. 38)
Priority Medicines for Europe and the World 2013 Update. Background Paper 8 - New Approaches to Promoting Innovation. BP 8.3 - Pricing and Reimbursement Policies: Impacts on Innovation
Pharmaceutical Policy and the Effects of the Economic Crisis: Estonia
Pharmaceutical Policy and the Effects of the Economic Crisis: Latvia
Pharmaceutical Policy and the Effects of the Economic Crisis: Lithuania
What Do We Really Know about Reference Pricing for Pharmaceuticals? Evidence from a Systematic Review of the Literature
WHO Guideline on Country Pharmaceutical Pricing Policies
Value in Pharmaceutical Pricing. OECD Health Working Papers No. 63
Effect of the Economic Recession on Pharmaceutical Policy and Medicine Sales in Eight European Countries
WHO Essential Medicines Policies and Use in Developing and Transitional Countries: An Analysis of Reported Policy Implementation and Medicines Use Surveys
Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research
Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
Developing an Approach for Using Health Technology Assessments in Reimbursement Systems for Medical Products. Geneva, Switzerland, July 20-21, 2015
Abstracts from the 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015
3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Country Poster Book

Related links:

http://whocc.goeg.at/Conference2015/Programmehttp://www.who.int/medicines/access/en/http://www.haiweb.org/medicineprices/http://www.joppp.org/

Regions:

Global
 
Open this document and view its content

3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Country Poster Book

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Financing
Medicine Access and Rational Use > Pricing

Year:

2015;

Pages:

44;

Publishers:

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies

Related documents:

Pharmaceuticals: Cost cointainment, Pricing, Reimbursement. World Bank, HNP Brief #7
Pharmaceutical Pricing and Reimbursement Information (PPRI), Austria, September 2008
Pharmaceutical Policies in European Countries in Response to the Global Financial Crisis - Southern Med Review Vol 4 Issue 2 Dec 2011
Pharmaceutical Pricing Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 9)
Pharmaceutical Pricing Policies in a Global Market. OECD Health Policy Studies
Cost-containment Policies in Public Pharmaceutical Spending in the EU. Economic Papers 461. September 2012 (European Economy/European Commission)
The World Medicines Situation 2011 (Chapters Currently Available)
Pharma Futures. Pathways to Value: Pharma in a Changing World. PharmaFutures Global Conclusions
Priority Medicines for Europe and the World 2013 Update (EMP Research Series No. 38)
Priority Medicines for Europe and the World 2013 Update. Background Paper 8 - New Approaches to Promoting Innovation. BP 8.3 - Pricing and Reimbursement Policies: Impacts on Innovation
Pharmaceutical Policy and the Effects of the Economic Crisis: Estonia
Pharmaceutical Policy and the Effects of the Economic Crisis: Latvia
Pharmaceutical Policy and the Effects of the Economic Crisis: Lithuania
What Do We Really Know about Reference Pricing for Pharmaceuticals? Evidence from a Systematic Review of the Literature
WHO Guideline on Country Pharmaceutical Pricing Policies
Value in Pharmaceutical Pricing. OECD Health Working Papers No. 63
Effect of the Economic Recession on Pharmaceutical Policy and Medicine Sales in Eight European Countries
WHO Essential Medicines Policies and Use in Developing and Transitional Countries: An Analysis of Reported Policy Implementation and Medicines Use Surveys
Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research
Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
Developing an Approach for Using Health Technology Assessments in Reimbursement Systems for Medical Products. Geneva, Switzerland, July 20-21, 2015
Abstracts from the 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015
3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Abstract Poster Book

Related links:

http://whocc.goeg.at/Conference2015/Programmehttp://www.who.int/medicines/access/en/http://www.haiweb.org/medicineprices/http://www.joppp.org/

Regions:

Global
 
Open this document and view its content

43rd WHA Reaffirms Revised Drug Strategy. Essential Drugs Monitor No. 010 (1990)

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy

Year:

1990;

Pages:

3;

Publishers:

WHO Headquarters in Geneva

Related documents:

Essential Drugs Monitor No. 010 (1990)

Related links:

http://www.who.int/medicines/publications/monitor/en/index.html

Regions:

Global
 
Open this document and view its content

44a Asamblea Mundial de la Salud - Parte 1. Proyecto de Principios Rectores sobre Trasplante de Órganos Humanos [Arabic] [Chinese] [English] [French] [Russian]

Subjects:

Transplantation > Organs

Year:

1991;

Pages:

5;

Publishers:

WHO Headquarters in Geneva

Related documents:

WHA44.25 - Human Organ Transplantation. WHA resolution; Forty-fourth World Health Assembly, 1991

Regions:

Global
 
Open this document and view its content

70 Years of Who Standards on Medicines Quality Expert Committee on Specifications for Pharmaceutical Preparations, 1947-2017: Addressing Changing Public Health Challenges. (Who Drug Information Vol. 31, No. 1, 2017)

Subjects:

Quality and Safety: Medicines > Quality Assurance
Quality and Safety: Medicines > Regulatory Support
WHO Prequalification of Medical Products > WHO-UNICEF-UN Project

Year:

2017;

Pages:

12;

Publishers:

WHO Headquarters in Geneva

Related documents:

WHO Expert Committee on Specifications for Pharmaceutical Preparations. How Does It Work?
Quality Assurance of Pharmaceuticals: Meeting a Major Public Health Challenge. WHO Expert Committee on Specifications for Pharmaceutical Preparations
WHO Drug Information Vol. 31, No. 1, 2017 - Recommended International Nonproprietary Names, List 77
A Quiet Revolution in Global Public Health: The World Health Organization’s Prequalification of Medicines Programme
A39/13 - Who's Revised Drug Strategy. Report by the Director-general, Thirty-ninth World Health Assembly, 1986

Related links:

http://www.who.int/medicines/publications/druginformation/en/index.htmlhttp://www.who.int/medicines/publications/pharmprep/en/http://www.who.int/medicines/areas/quality_safety/quality_assurance/en/http://www.who.int/medicines/areas/quality_safety/quality_assurance/expert_committee/en/http://www.who.int/medicines/regulation/prequalification/en/http://www.who.int/about/collaborations/expert_panels/en/http://apps.who.int/iris/bitstream/10665/38882/1/WHO_TRS_1.pdf

Regions:

Global
 
Open this document and view its content

A39/13 - Estrategia Revisada De La Oms En Materia De Medicamentos. Informe Del Director General, 39a Asamblea Mundial De La Salud, 1986 [English] [French]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Rational Use

Year:

1986;

Pages:

10;

Publishers:

WHO Headquarters in Geneva

Related documents:

A54/17 - Revised Drug Strategy. Report by the Secretariat, Fifty-fourth World Health Assembly, 2001
The Rational Use of Drugs - Report of the Conference of Experts, Nairobi 25-29 November 1985
WHA52.19 - Estrategia revisada en materia de medicamentos. Resolución WHA; 52a Asamblea Mundial de la Salud, 1999
WHA49.14 - Revised Drug Strategy. WHA Resolution; Forty-ninth World Health Assembly, 1996
WHA54.11 - Estrategia farmacéutica de la OMS. Resolución WHA; 54a Asamblea Mundial de la Salud, 2001
WHA37.33 - Uso racional de los medicamentos. Resolución WHA; 37a Organización Mundial de la Salud, 1984

Related links:

http://www.who.int/governance/es/http://www.who.int/medicines/en/http://apps.who.int/medicinedocs/permalinks/open/periodicals/who-publications/all/english/world-health-assembly-wha-and-executive-board-eb-resolutions-and-documentation

Regions:

Global
 
Open this document and view its content

A39/13 - Stratégie pharmaceutique révisée. Rapport du Directeur général, Trente-Neuvième Assemblée mondiale de la Santé, 1986 [English] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Rational Use

Year:

1986;

Pages:

11;

Publishers:

WHO Headquarters in Geneva

Related documents:

A54/17 - Revised Drug Strategy. Report by the Secretariat, Fifty-fourth World Health Assembly, 2001
The Rational Use of Drugs - Report of the Conference of Experts, Nairobi 25-29 November 1985
WHA52.19 - Stratégie pharmaceutique révisée. WHA résolution; Cinquante-Deuxième Assemblée mondiale de la Santé, 1999
WHA49.14 - Revised Drug Strategy. WHA Resolution; Forty-ninth World Health Assembly, 1996
WHA54.11 - Stratégie pharmaceutique de l’OMS. WHA résolution; Cinquante-Quatrième Assemblée mondiale de la Santé, 2001
WHA37.33 - Usage rationnel des médicaments. WHA Résolution; Trente-Septième Assemblée mondiale de la Santé, 1984

Related links:

http://www.who.int/governance/fr/http://www.who.int/medicines/en/http://apps.who.int/medicinedocs/permalinks/open/periodicals/who-publications/all/english/world-health-assembly-wha-and-executive-board-eb-resolutions-and-documentation

Regions:

Global
 
Open this document and view its content

A39/13 - Who's Revised Drug Strategy. Report by the Director-general, Thirty-ninth World Health Assembly, 1986 [French] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Rational Use

Year:

1986;

Pages:

9;

Publishers:

WHO Headquarters in Geneva

Related documents:

WHA54.11 - WHO Medicines Strategy. WHA Resolution; Fifty-fourth World Health Assembly, 2001
A54/17 - Revised Drug Strategy. Report by the Secretariat, Fifty-fourth World Health Assembly, 2001
The Rational Use of Drugs - Report of the Conference of Experts, Nairobi 25-29 November 1985
WHA52.19 - Revised Drug Strategy. WHA Resolution; Fifty-second World Health Assembly, 1999
WHA49.14 - Revised Drug Strategy. WHA Resolution; Forty-ninth World Health Assembly, 1996
WHA37.33 - Rational Use of Drug. WHA Resolution; Thirty-seventh World Health Assembly, 1984

Related links:

http://www.who.int/governance/en/http://www.who.int/medicines/en/http://apps.who.int/medicinedocs/permalinks/open/periodicals/who-publications/all/english/world-health-assembly-wha-and-executive-board-eb-resolutions-and-documentation

Regions:

Global
 
Open this document and view its content

A51/9 - Emerging and Other Communicable Diseases: Antimicrobial Resistance. Report by the Secretariat, Fifty-first World Health Assembly, 1998

Subjects:

Medicine Access and Rational Use > Antimicrobial Drug Resistance
Medicine Access and Rational Use > Rational Use

Year:

1998;

Pages:

4;

Publishers:

WHO Headquarters in Geneva

Related documents:

Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings. Report on Five Pilot Projects - EDM Research Series No. 037
WHA51.17 - Emerging and Other Communicable Diseases: Antimicrobial Resistance. WHA Resolution; Fifty-first World Health Assembly, 1998
A58/14 - Antimicrobial Resistance: a Threat to Global Health Security. Rational Use of Medicines by Prescribers and Patients. Report by the Secretariat, Fifty-eighth World Health Assembly, 2005
WHA 2007. A60/28 - Progress Reports on Technical and Health Matters. Improving the containment of antimicrobial resistance (resolution WHA58). Report by the Secretariat, Sixtieth World Health Assembly, 2007
WHA58.27 - Improving the Containment of Antimicrobial Resistance. WHA resolution; Fifty-eighth World Health Assembly, 2005
WHO Global Strategy for Containment of Antimicrobial Resistance
The WHO Policy Package to Combat Antimicrobial Resistance
The Evolving Threat of Antimicrobial Resistance: Options for Action
Antimicrobial Resistance. Resolutions of the World Health Assembly and WHO Regional Committee for South-East Asia. Use Antibiotics Rationally
Regional Strategy on Prevention and Containment of Antimicrobial Resistance 2010-2015
Priority Medicines for Europe and the World 2013 Update. Background Paper 6 - Priority Diseases and Reasons for Inclusion. BP 6.01 - Antimicrobial Resistance
Antimicrobial Resistance: Global Report on Surveillance, 2014
WHA67.25 - Antimicrobial Resistance. WHA resolution; Sixty-seventh World Health Assembly, 2014
WHA68.7 - Global Action Plan on Antimicrobial Resistance. WHA Resolution; Sixty-eighth World Health Assembly, 2015
Antimicrobial Resistance in the Western Pacific Region. A Review of Surveillance and Health Systems Response
Global Action Plan on Antimicrobial Resistance (2015)
Central Asian and Eastern European Surveillance of Antimicrobial Resistance. Annual Report 2016
Antimicrobial Resistance Surveillance in Europe. Annual Report of the European Antimicrobial Resistance Surveillance Network (Ears-net) 2014

Related links:

http://www.who.int/governance/en/index.htmlhttp://www.who.int/antimicrobial-resistance/en/http://www.who.int/medicines/areas/rational_use/emp_amr/en/http://apps.who.int/medicinedocs/permalinks/open/subjects/all/all/english/medicine-access-and-rational-use/antimicrobial-drug-resistance

Regions:

Global
 
Open this document and view its content

A54/17 - Estrategia revisada en materia de medicamentos. Informe de la Secretaría, 54a Asamblea Mundial de la Salud, 2001 [English] [French]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Antimicrobial Drug Resistance
Medicine Access and Rational Use > Rational Use

Year:

2001;

Pages:

8;

Publishers:

WHO Headquarters in Geneva

Related documents:

WHA52.19 - Estrategia revisada en materia de medicamentos. Resolución WHA; 52a Asamblea Mundial de la Salud, 1999
WHA49.14 - Revised Drug Strategy. WHA Resolution; Forty-ninth World Health Assembly, 1996
A39/13 - Who's Revised Drug Strategy. Report by the Director-general, Thirty-ninth World Health Assembly, 1986
WHA37.33 - Uso racional de los medicamentos. Resolución WHA; 37a Organización Mundial de la Salud, 1984

Related links:

http://www.who.int/governance/es/http://www.who.int/medicines/en/http://apps.who.int/medicinedocs/permalinks/open/periodicals/who-publications/all/english/world-health-assembly-wha-and-executive-board-eb-resolutions-and-documentation

Regions:

Global
 
Open this document and view its content

A54/17 - Revised Drug Strategy. Report by the Secretariat, Fifty-fourth World Health Assembly, 2001 [French] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Antimicrobial Drug Resistance
Medicine Access and Rational Use > Rational Use

Year:

2001;

Pages:

7;

Publishers:

WHO Headquarters in Geneva

Related documents:

WHA52.19 - Revised Drug Strategy. WHA Resolution; Fifty-second World Health Assembly, 1999
WHA49.14 - Revised Drug Strategy. WHA Resolution; Forty-ninth World Health Assembly, 1996
A39/13 - Who's Revised Drug Strategy. Report by the Director-general, Thirty-ninth World Health Assembly, 1986
WHA37.33 - Rational Use of Drug. WHA Resolution; Thirty-seventh World Health Assembly, 1984

Related links:

http://www.who.int/governance/en/http://www.who.int/medicines/en/http://apps.who.int/medicinedocs/permalinks/open/periodicals/who-publications/all/english/world-health-assembly-wha-and-executive-board-eb-resolutions-and-documentation

Regions:

Global
 
Open this document and view its content

A54/17 - Stratégie pharmaceutique révisée. Rapport du Secrétariat, Cinquante-Quatrième Assemblée mondiale de la Santé, 2001 [English] [Spanish]

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Antimicrobial Drug Resistance
Medicine Access and Rational Use > Rational Use

Year:

2001;

Pages:

8;

Publishers:

WHO Headquarters in Geneva

Related documents:

WHA52.19 - Stratégie pharmaceutique révisée. WHA résolution; Cinquante-Deuxième Assemblée mondiale de la Santé, 1999
WHA49.14 - Revised Drug Strategy. WHA Resolution; Forty-ninth World Health Assembly, 1996
A39/13 - Who's Revised Drug Strategy. Report by the Director-general, Thirty-ninth World Health Assembly, 1986
WHA37.33 - Usage rationnel des médicaments. WHA Résolution; Trente-Septième Assemblée mondiale de la Santé, 1984

Related links:

http://www.who.int/governance/fr/http://www.who.int/medicines/en/http://apps.who.int/medicinedocs/permalinks/open/periodicals/who-publications/all/english/world-health-assembly-wha-and-executive-board-eb-resolutions-and-documentation

Regions:

Global
 
Open this document and view its content

A54/9 - Global health security - epidemic alert and response. Report by the Secretariat, Fifty-fourth World Health Assembly, 2001

Subjects:

Medicine Access and Rational Use > Antimicrobial Drug Resistance
Medicine Access and Rational Use > Rational Use

Year:

2001;

Pages:

2;

Publishers:

WHO Headquarters in Geneva

Related links:

http://www.who.int/governance/en/index.htmlhttp://www.who.int/medicines/areas/rational_use/emp_amr/en/http://www.who.int/antimicrobial-resistance/en/http://apps.who.int/medicinedocs/permalinks/open/subjects/all/all/english/medicine-access-and-rational-use/antimicrobial-drug-resistance

Regions:

Global
 
Open this document and view its content

A55/13 - Quality of Care: Patient Safety. Report by the Secretariat, World Health Assembly, 2002

Subjects:

Emergency and Essential Surgical Care > Surgical Safety
Emergency and Essential Surgical Care > Surgical Procedures

Year:

2002;

Pages:

6;

Publishers:

WHO Headquarters in Geneva

Related links:

http://www.who.int/governance/en/index.htmlhttp://www.who.int/topics/patient_safety/en/http://www.who.int/medicines/en/

Regions:

Global
 
Open this document and view its content

A58/14 - Antimicrobial Resistance: a Threat to Global Health Security. Rational Use of Medicines by Prescribers and Patients. Report by the Secretariat, Fifty-eighth World Health Assembly, 2005

Subjects:

Medicine Access and Rational Use > Antimicrobial Drug Resistance
Medicine Access and Rational Use > Rational Use

Year:

2005;

Pages:

6;

Publishers:

WHO Headquarters in Geneva

Related documents:

A51/9 - Emerging and Other Communicable Diseases: Antimicrobial Resistance. Report by the Secretariat, Fifty-first World Health Assembly, 1998
Antimicrobial Resistance in the Western Pacific Region. A Review of Surveillance and Health Systems Response
Antimicrobial Resistance. Resolutions of the World Health Assembly and WHO Regional Committee for South-East Asia. Use Antibiotics Rationally
Antimicrobial Resistance: Global Report on Surveillance, 2014
Central Asian and Eastern European Surveillance of Antimicrobial Resistance. Annual Report 2016
Global Action Plan on Antimicrobial Resistance (2015)
Regional Strategy on Prevention and Containment of Antimicrobial Resistance 2010-2015
The Evolving Threat of Antimicrobial Resistance: Options for Action
WHA 2007. A60/28 - Progress Reports on Technical and Health Matters. Improving the containment of antimicrobial resistance (resolution WHA58). Report by the Secretariat, Sixtieth World Health Assembly, 2007
WHA51.17 - Emerging and Other Communicable Diseases: Antimicrobial Resistance. WHA Resolution; Fifty-first World Health Assembly, 1998
WHA58.27 - Improving the Containment of Antimicrobial Resistance. WHA resolution; Fifty-eighth World Health Assembly, 2005
WHA67.25 - Antimicrobial Resistance. WHA resolution; Sixty-seventh World Health Assembly, 2014
WHA68.7 - Global Action Plan on Antimicrobial Resistance. WHA Resolution; Sixty-eighth World Health Assembly, 2015
WHO Global Strategy for Containment of Antimicrobial Resistance

Related links:

http://www.who.int/medicines/areas/rational_use/emp_amr/en/http://www.who.int/antimicrobial-resistance/en/http://apps.who.int/medicinedocs/permalinks/open/subjects/all/all/english/medicine-access-and-rational-usehttp://www.who.int/governance/en/index.html

Regions:

Global
 
Open this document and view its content

Abstracts from the 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Financing
Medicine Access and Rational Use > Pricing

Author:

Babar, Zaheer-Ud-Din; Vogler, Sabine; Zimmermann, Nina

Year:

2015;

Pages:

30;

Related documents:

Pharmaceuticals: Cost cointainment, Pricing, Reimbursement. World Bank, HNP Brief #7
Pharmaceutical Pricing and Reimbursement Information (PPRI), Austria, September 2008
Pharmaceutical Policies in European Countries in Response to the Global Financial Crisis - Southern Med Review Vol 4 Issue 2 Dec 2011
Pharmaceutical Pricing Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 9)
Pharmaceutical Pricing Policies in a Global Market. OECD Health Policy Studies
Cost-containment Policies in Public Pharmaceutical Spending in the EU. Economic Papers 461. September 2012 (European Economy/European Commission)
The World Medicines Situation 2011 (Chapters Currently Available)
Pharma Futures. Pathways to Value: Pharma in a Changing World. PharmaFutures Global Conclusions
Priority Medicines for Europe and the World 2013 Update (EMP Research Series No. 38)
Priority Medicines for Europe and the World 2013 Update. Background Paper 8 - New Approaches to Promoting Innovation. BP 8.3 - Pricing and Reimbursement Policies: Impacts on Innovation
Pharmaceutical Policy and the Effects of the Economic Crisis: Estonia
Pharmaceutical Policy and the Effects of the Economic Crisis: Latvia
Pharmaceutical Policy and the Effects of the Economic Crisis: Lithuania
What Do We Really Know about Reference Pricing for Pharmaceuticals? Evidence from a Systematic Review of the Literature
WHO Guideline on Country Pharmaceutical Pricing Policies
Value in Pharmaceutical Pricing. OECD Health Working Papers No. 63
Effect of the Economic Recession on Pharmaceutical Policy and Medicine Sales in Eight European Countries
WHO Essential Medicines Policies and Use in Developing and Transitional Countries: An Analysis of Reported Policy Implementation and Medicines Use Surveys
Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research
Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
Developing an Approach for Using Health Technology Assessments in Reimbursement Systems for Medical Products. Geneva, Switzerland, July 20-21, 2015
3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Abstract Poster Book
3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Country Poster Book

Related links:

http://whocc.goeg.at/Conference2015/Programmehttp://www.who.int/medicines/access/en/http://www.haiweb.org/medicineprices/http://www.joppp.org/

Regions:

Global
 
Open this document and view its content

Accelerated Stability Studies of Widely Used Pharmaceutical Substances Under Simulated Tropical Conditions View the PDF document

Subjects:

Quality and Safety: Medicines > Quality Assurance

Year:

1986;

Pages:

119;

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

Accelerating Progress on HIV, Tuberculosis, Malaria, Hepatitis and Neglected Tropical Diseases. A New Agenda for 2016 - 2030

Subjects:

Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Rational Use
Medicine Access and Rational Use > Supply Management

Year:

2015;

Pages:

79;

Publishers:

WHO Headquarters in Geneva

Related documents:

UN Millennium Project. 2005. Prescription for Healthy Development: Increasing Access to Medicines. Report of the Task Force on HIV/AIDS, Malaria, TB, and Access to Essential Medicines, Working Group on Access to Essential Medicines.
The World Health Report 2010. Health Systems Financing: The Path to Universal Coverage
The World Health Report 2013. Research for Universal Health Coverage
Essential Medicines and Health Products - Biennial Report 2012–2013
Investing to Overcome the Global Impact of Neglected Tropical Diseases: Third WHO Report on Neglected Diseases 2015
Global Tuberculosis Report 2015. (20th edition)
World Malaria Report 2015
Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals

Related links:

http://www.who.int/hiv/en/http://www.who.int/neglected_diseases/en/http://www.who.int/malaria/en/http://www.who.int/tb/en/http://www.who.int/hepatitis/en/

Regions:

Global
 
Open this document and view its content

El acceso a los medicamentos en el contexto del derecho de toda persona al disfrute del más alto nivel posible de salud física y mental. A/HRC/32/L.23/Rev.1, 30 de junio de 2016. Consejo de Derechos Humanos, 32º período de sesiones [Arabic] [Chinese] [English] [French] [Russian]

Subjects:

Medicine Information and Evidence for Policy > Human Rights
Medicine Information and Evidence for Policy > Medicines Policy

Year:

2016;

Pages:

6;

Publishers:

United Nations Human Rights (OHCHR) - Human Rights Council (HRC)

Related documents:

Essential Medicines and Human Rights: What Can They Learn From Each Other?
Is Access to Essential Medicines As Part Of The Fulfilment of the Right to Health Enforceable Through the Courts?
Health, Essential Medicines, Human Rights & National Constitutions
The World Medicines Situation 2011 - Access to Essential Medicines as Part of the Right to Health
A Right to Health
Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property
Respecting the Right to Access to Medicines: Implications of the UN Guiding Principles on Business and Human Rights for the Pharmaceutical Industry
Health Technologies and Pharmaceuticals Division of Health Systems and Public Health. Annual Report 2012, WHO/Europe. Access to essential, quality medicines and health technologies is a fundamental part of every person’s right to health
El derecho a la salud y a los medicamentos: el caso de las recientes negociaciones sobre la estrategia mundial sobre la salud pública, la innovación y la propiedad intelectual. (El Centro de Sur - Documentos de Investigación 35, Enero de 2011)
The Doha Declaration Ten Years on and Its Impact on Access to Medicines and the Right to Health, 2011. Discussion Paper, UNDP
Veinticinco preguntas y respuestas sobre salud y derechos humanos

Related links:

http://www.ohchr.org/SP/HRBodies/HRC/Pages/HRCIndex.aspxhttps://documents-dds-ny.un.org/http://www.un.org/es/universal-declaration-human-rights/http://www.who.int/hhr/en/http://www.who.int/medicines/areas/human_rights/en/

Regions:

Global
 
Open this document and view its content

Acceso equitativo a los medicamentos esenciales: Un marco para la acción colectiva - Perspectivas políticas de la OMS sobre medicamentos, No. 08, marzo de 2004 [English] [French] View the PDF document

Subjects:

Medicine Access and Rational Use > Rational Use

Year:

2004;

Pages:

6;

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

Access and Control Newsletter

Subjects:

Medicine Access and Rational Use > Controlled Medicines

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

Access and Control Newsletter. No 001, February 2008

Year:

2008;

Pages:

1;

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

Access and Control Newsletter. No 002, May 2008

Year:

2008;

Pages:

3;

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

Access and Control Newsletter. No 003, November 2008

Year:

2008;

Pages:

2;

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
Open this document and view its content

Access and Control Newsletter. No 004, September 2009

Year:

2009;

Pages:

5;

Publishers:

WHO Headquarters in Geneva

Regions:

Global
 
 
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: July 10, 2017